1Uthors CP. Effectiveness of multimedia interactive patient educa- tion on knowledge, uncertainty and decision-making in patients with end-stage renal disease. Clin Nurs, 2012,21 ( 9-10 ) : 1223- 1231.
2Ollinger C. Computer-based tutorial to enhance the quality and ef- ficiency of the informed-consent process for cataract surgery. Cata- ract Refract Surg,2012,38(4) :655-659.
4Phum N, Malduaato A, Bfoiae D, et al. The narrative-autobiographic appproaeh in the group education of adolescents with diabetes: aqualitative research on its effects. Patient Educ Coma,2010, 80 (1) :56-63.
5Frazao JM, Adragao T. Non-calcium-containing phosphate binders comparing efficacy, safety, and other clinical effects. Nephron Clin Pract ,2012,120 (2) : c108-cl 19.
6Berns J S. Niacin and related compounds for treating hyperphos- phatemia in dialysis patients. Seminars in Dialysis,2008,21 (3) : 203 -205.
7Shimoda K, Akiba T, Matsushima T, et al. Nieeritrol decreases se- rum phosphate levels in chronic hemodialysis patients. Nihon Jinzo Gakkai SHI,1998,40( 1 ) :1-7.
8Checheritai A, Smarandache D, David C, et al. Vascular calcifica- tions in chronic kidney disease-clinical management. ROM J Morphol Embryol,2012,53 (1) :7-13.
9Sampathkumar K,Selvam M,Soaraj S, et al. Extended release nic- otinic acid-a novel oral agent for phosphate control. Inter Urol Nephro1,2006,38 ( 1 ) : 171-174.
10Shahbazian H, Zafar MA, Ghorbani A, et al. Oral nicotinamide re- duces serum phosphorus, increases HDL, and induces thrombocy- topenia in hemodialysis patients:a double-blind randomized clini- cal trial. Nefrologa: Publicaci6n Oficial DE LA Sociedad ES, 2011,31 ( 1 ) :58-65.
